Index
1 Immune Globulin Intravenous Market Overview
1.1 Product Overview and Scope of Immune Globulin Intravenous
1.2 Immune Globulin Intravenous Segment by Type
1.2.1 Global Immune Globulin Intravenous Market Value Comparison by Type (2024-2030)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Immune Globulin Intravenous Segment by Application
1.3.1 Global Immune Globulin Intravenous Market Value by Application: (2024-2030)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Immune Globulin Intravenous Market Size Estimates and Forecasts
1.4.1 Global Immune Globulin Intravenous Revenue 2019-2030
1.4.2 Global Immune Globulin Intravenous Sales 2019-2030
1.4.3 Global Immune Globulin Intravenous Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Immune Globulin Intravenous Market Competition by Manufacturers
2.1 Global Immune Globulin Intravenous Sales Market Share by Manufacturers (2019-2024)
2.2 Global Immune Globulin Intravenous Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Immune Globulin Intravenous Average Price by Manufacturers (2019-2024)
2.4 Global Immune Globulin Intravenous Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immune Globulin Intravenous, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Globulin Intravenous, Product Type & Application
2.7 Immune Globulin Intravenous Market Competitive Situation and Trends
2.7.1 Immune Globulin Intravenous Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immune Globulin Intravenous Players Market Share by Revenue
2.7.3 Global Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immune Globulin Intravenous Retrospective Market Scenario by Region
3.1 Global Immune Globulin Intravenous Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Immune Globulin Intravenous Global Immune Globulin Intravenous Sales by Region: 2019-2030
3.2.1 Global Immune Globulin Intravenous Sales by Region: 2019-2024
3.2.2 Global Immune Globulin Intravenous Sales by Region: 2025-2030
3.3 Global Immune Globulin Intravenous Global Immune Globulin Intravenous Revenue by Region: 2019-2030
3.3.1 Global Immune Globulin Intravenous Revenue by Region: 2019-2024
3.3.2 Global Immune Globulin Intravenous Revenue by Region: 2025-2030
3.4 North America Immune Globulin Intravenous Market Facts & Figures by Country
3.4.1 North America Immune Globulin Intravenous Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Immune Globulin Intravenous Sales by Country (2019-2030)
3.4.3 North America Immune Globulin Intravenous Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Immune Globulin Intravenous Market Facts & Figures by Country
3.5.1 Europe Immune Globulin Intravenous Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Immune Globulin Intravenous Sales by Country (2019-2030)
3.5.3 Europe Immune Globulin Intravenous Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Globulin Intravenous Market Facts & Figures by Country
3.6.1 Asia Pacific Immune Globulin Intravenous Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Immune Globulin Intravenous Sales by Country (2019-2030)
3.6.3 Asia Pacific Immune Globulin Intravenous Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Immune Globulin Intravenous Market Facts & Figures by Country
3.7.1 Latin America Immune Globulin Intravenous Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Immune Globulin Intravenous Sales by Country (2019-2030)
3.7.3 Latin America Immune Globulin Intravenous Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Globulin Intravenous Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Globulin Intravenous Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Immune Globulin Intravenous Sales by Country (2019-2030)
3.8.3 Middle East and Africa Immune Globulin Intravenous Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immune Globulin Intravenous Sales by Type (2019-2030)
4.1.1 Global Immune Globulin Intravenous Sales by Type (2019-2024)
4.1.2 Global Immune Globulin Intravenous Sales by Type (2025-2030)
4.1.3 Global Immune Globulin Intravenous Sales Market Share by Type (2019-2030)
4.2 Global Immune Globulin Intravenous Revenue by Type (2019-2030)
4.2.1 Global Immune Globulin Intravenous Revenue by Type (2019-2024)
4.2.2 Global Immune Globulin Intravenous Revenue by Type (2025-2030)
4.2.3 Global Immune Globulin Intravenous Revenue Market Share by Type (2019-2030)
4.3 Global Immune Globulin Intravenous Price by Type (2019-2030)
5 Segment by Application
5.1 Global Immune Globulin Intravenous Sales by Application (2019-2030)
5.1.1 Global Immune Globulin Intravenous Sales by Application (2019-2024)
5.1.2 Global Immune Globulin Intravenous Sales by Application (2025-2030)
5.1.3 Global Immune Globulin Intravenous Sales Market Share by Application (2019-2030)
5.2 Global Immune Globulin Intravenous Revenue by Application (2019-2030)
5.2.1 Global Immune Globulin Intravenous Revenue by Application (2019-2024)
5.2.2 Global Immune Globulin Intravenous Revenue by Application (2025-2030)
5.2.3 Global Immune Globulin Intravenous Revenue Market Share by Application (2019-2030)
5.3 Global Immune Globulin Intravenous Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Immune Globulin Intravenous Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Immune Globulin Intravenous Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Immune Globulin Intravenous Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Immune Globulin Intravenous Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biotest Immune Globulin Intravenous Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kedrion Immune Globulin Intravenous Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hualan Bio Immune Globulin Intravenous Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CNBG Immune Globulin Intravenous Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai RAAS Immune Globulin Intravenous Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Immune Globulin Intravenous Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group Immune Globulin Intravenous Description and Business Overview
6.11.3 LFB Group Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LFB Group Immune Globulin Intravenous Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Immune Globulin Intravenous Description and Business Overview
6.12.3 BPL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BPL Immune Globulin Intravenous Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Corporation Information
6.13.2 Sichuan Yuanda Shuyang Immune Globulin Intravenous Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Globulin Intravenous Industry Chain Analysis
7.2 Immune Globulin Intravenous Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Globulin Intravenous Production Mode & Process
7.4 Immune Globulin Intravenous Sales and Marketing
7.4.1 Immune Globulin Intravenous Sales Channels
7.4.2 Immune Globulin Intravenous Distributors
7.5 Immune Globulin Intravenous Customers
8 Immune Globulin Intravenous Market Dynamics
8.1 Immune Globulin Intravenous Industry Trends
8.2 Immune Globulin Intravenous Market Drivers
8.3 Immune Globulin Intravenous Market Challenges
8.4 Immune Globulin Intravenous Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer